Vesper Bio awarded grant by Michael J. Fox Foundation to assess sortilin inhibitors for Parkinson’s disease

Vesper Bio awarded grant by Michael J. Fox Foundation to assess sortilin inhibitors for Parkinson’s disease

Submitted by admin on January 25, 2024 - 10:57am
Source: 
Biopharma Reporter
News Tags: 
Vesper Bio
Michael J Fox Foundation
grants
sortilin
Headline: 
Vesper Bio awarded grant by Michael J. Fox Foundation to assess sortilin inhibitors for Parkinson’s disease
snippet: 

Danish biotech company Vesper Bio has been awarded a grant worth $873,000 by The Michael J. Fox Foundation (MJFF) to assess sortilin inhibition in Parkinson's disease.

Do Not Allow Advertisers to Use My Personal information